Imunon, Inc. (IMNN) stock forecast and price target
Price $0.63 · data as of November 13, 2026
12-month price target
Average target$15.20
Upside / downside+2316.5%
Analysts5
ConsensusStrong buy
Low $6.00Average $15.20High $25.00
Gold marker: average target · white marker: today’s price ($0.63)
Analyst ratings
Strong buy 1Buy 3Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-2.58 | +62.2% | $0 |
| Next fiscal year ends December 31, 2027 | $-1.68 | +34.9% | $0 |
| Next quarter ends December 31, 2026 | $-0.60 | +53.6% | $0 |
| Quarter after ends March 31, 2027 | $-0.56 | +32.7% | $0 |
Consensus of the analysts covering Imunon, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.
Frequently asked questions
What is the Imunon stock price target?
The average 12-month target from 5 analysts is $15.20, 2316.5% above the current price of $0.63 Targets range from $6.00 to $25.00.
Is Imunon a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Imunon expected to earn?
Analysts expect EPS of $-2.58 for the fiscal year ending December 31, 2026 and $-1.68 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.